New Treatments? Clinical Trials New Treatment

SGN 30, Anti- CD30 monoclonal- This drug is being tested for patients diagnosed in the early stages of ALCL. Monoclonal antibodies like SGN-30 can block cancer growth in different ways.

Pralatrexate treats peripheral T-cell lymphoma in patients that haven’t gotten better with chemotherapy or often come back.

A number of scientists are studying a combination of the SGN 30 and chemotherapy that would kill the cancer cells faster.